Meeting ReportOncology, Basic Science Track
Phase I trial of alpha-particle immunotherapy with 225Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia.
Joseph Jurcic, Moshe Levy, Jae Park, Farhad Ravandi, Alexander Perl, John Pagel, B Smith, Johnnie Orozco, Elihu Estey, Hagop Kantarjian, Dragan Cicic and David Scheinberg
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 456;
Joseph Jurcic
2Columbia University Medical Center New York NY United States
Moshe Levy
8Texas Oncology-Baylor University Dallas TX United States
Jae Park
6Memorial Sloan Kettering Cancer Center New York NY United States
Farhad Ravandi
5M.D. Anderson Cancer Center Houston TX United States
Alexander Perl
9University of Pennsylvania Philadelphia PA United States
John Pagel
7Swedish Medical Center Seattle WA United States
B Smith
4Johns Hopkins University Baltimore MD United States
Johnnie Orozco
3Fred Hutchinson Cancer Research Center Seattle WA United States
Elihu Estey
3Fred Hutchinson Cancer Research Center Seattle WA United States
Hagop Kantarjian
5M.D. Anderson Cancer Center Houston TX United States
Dragan Cicic
1Actinium Pharmaceuticals, Inc. New York NY United States
David Scheinberg
6Memorial Sloan Kettering Cancer Center New York NY United States
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
Phase I trial of alpha-particle immunotherapy with 225Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia.
Joseph Jurcic, Moshe Levy, Jae Park, Farhad Ravandi, Alexander Perl, John Pagel, B Smith, Johnnie Orozco, Elihu Estey, Hagop Kantarjian, Dragan Cicic, David Scheinberg
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 456;
Phase I trial of alpha-particle immunotherapy with 225Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia.
Joseph Jurcic, Moshe Levy, Jae Park, Farhad Ravandi, Alexander Perl, John Pagel, B Smith, Johnnie Orozco, Elihu Estey, Hagop Kantarjian, Dragan Cicic, David Scheinberg
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 456;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.